296 related articles for article (PubMed ID: 32029330)
1. Correction of autophagy impairment inhibits pathology in the NOD.H-2h4 mouse model of primary Sjögren's syndrome.
Voynova E; Lefebvre F; Qadri A; Muller S
J Autoimmun; 2020 Mar; 108():102418. PubMed ID: 32029330
[TBL] [Abstract][Full Text] [Related]
2. Short-chain fatty acid butyrate induces IL-10-producing B cells by regulating circadian-clock-related genes to ameliorate Sjögren's syndrome.
Kim DS; Woo JS; Min HK; Choi JW; Moon JH; Park MJ; Kwok SK; Park SH; Cho ML
J Autoimmun; 2021 May; 119():102611. PubMed ID: 33631650
[TBL] [Abstract][Full Text] [Related]
3. Rescue of autophagy and lysosome defects in salivary glands of MRL/lpr mice by a therapeutic phosphopeptide.
Li B; Wang F; Schall N; Muller S
J Autoimmun; 2018 Jun; 90():132-145. PubMed ID: 29486915
[TBL] [Abstract][Full Text] [Related]
4. Discerning the kinetics of autoimmune manifestations in a model of Sjögren's syndrome.
Karnell JL; Mahmoud TI; Herbst R; Ettinger R
Mol Immunol; 2014 Dec; 62(2):277-82. PubMed ID: 24907930
[TBL] [Abstract][Full Text] [Related]
5. Differentiation of follicular helper T cells by salivary gland epithelial cells in primary Sjögren's syndrome.
Gong YZ; Nititham J; Taylor K; Miceli-Richard C; Sordet C; Wachsmann D; Bahram S; Georgel P; Criswell LA; Sibilia J; Mariette X; Alsaleh G; Gottenberg JE
J Autoimmun; 2014 Jun; 51():57-66. PubMed ID: 24411167
[TBL] [Abstract][Full Text] [Related]
6. Early Covert Appearance of Marginal Zone B Cells in Salivary Glands of Sjögren's Syndrome-Susceptible Mice: Initiators of Subsequent Overt Clinical Disease.
Peck AB; Nguyen CQ; Ambrus J
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33671965
[TBL] [Abstract][Full Text] [Related]
7. Ly9 (CD229) Antibody Targeting Depletes Marginal Zone and Germinal Center B Cells in Lymphoid Tissues and Reduces Salivary Gland Inflammation in a Mouse Model of Sjögren's Syndrome.
Puñet-Ortiz J; Sáez Moya M; Cuenca M; Caleiras E; Lazaro A; Engel P
Front Immunol; 2018; 9():2661. PubMed ID: 30519241
[TBL] [Abstract][Full Text] [Related]
8. Salivary-gland-protective regulatory T-cell dysfunction underlies female-specific sialadenitis in the non-obese diabetic mouse model of Sjögren syndrome.
Barr JY; Wang X; Kreiger PA; Lieberman SM
Immunology; 2018 Oct; 155(2):225-237. PubMed ID: 29750331
[TBL] [Abstract][Full Text] [Related]
9. B-cell tolerance breakdown in Sjögren's syndrome: focus on BAFF.
Varin MM; Le Pottier L; Youinou P; Saulep D; Mackay F; Pers JO
Autoimmun Rev; 2010 Jul; 9(9):604-8. PubMed ID: 20457281
[TBL] [Abstract][Full Text] [Related]
10. Salivary gland changes in the NOD mouse model for Sjögren's syndrome: is there a non-immune genetic trigger?
Humphreys-Beher MG; Yamachika S; Yamamoto H; Maeda N; Nakagawa Y; Peck AB; Robinson CP
Eur J Morphol; 1998 Aug; 36 Suppl():247-51. PubMed ID: 9825931
[TBL] [Abstract][Full Text] [Related]
11. Metformin improves salivary gland inflammation and hypofunction in murine Sjögren's syndrome.
Kim JW; Kim SM; Park JS; Hwang SH; Choi J; Jung KA; Ryu JG; Lee SY; Kwok SK; Cho ML; Park SH
Arthritis Res Ther; 2019 Jun; 21(1):136. PubMed ID: 31164166
[TBL] [Abstract][Full Text] [Related]
12. The T cell in Sjogren's syndrome: force majeure, not spectateur.
Singh N; Cohen PL
J Autoimmun; 2012 Sep; 39(3):229-33. PubMed ID: 22709856
[TBL] [Abstract][Full Text] [Related]
13. Dysregulated Marginal Zone B Cell Compartment in a Mouse Model of Sjögren's Syndrome with Ocular Inflammation.
Singh N; Chin I; Gabriel P; Blaum E; Masli S
Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30314337
[TBL] [Abstract][Full Text] [Related]
14. NOD.H-2h4 mice: an important and underutilized animal model of autoimmune thyroiditis and Sjogren's syndrome.
Braley-Mullen H; Yu S
Adv Immunol; 2015; 126():1-43. PubMed ID: 25727287
[TBL] [Abstract][Full Text] [Related]
15. The role of caspase cascade on the development of primary Sjögren's syndrome.
Hayashi Y; Arakaki R; Ishimaru N
J Med Invest; 2003 Feb; 50(1-2):32-8. PubMed ID: 12630566
[TBL] [Abstract][Full Text] [Related]
16. LncRNA PVT1 links Myc to glycolytic metabolism upon CD4
Fu J; Shi H; Wang B; Zhan T; Shao Y; Ye L; Wu S; Yu C; Zheng L
J Autoimmun; 2020 Feb; 107():102358. PubMed ID: 31757716
[TBL] [Abstract][Full Text] [Related]
17. New concepts for the development of autoimmune exocrinopathy derived from studies with the NOD mouse model.
Humphreys-Beher MG; Peck AB
Arch Oral Biol; 1999 May; 44 Suppl 1():S21-5. PubMed ID: 10414851
[TBL] [Abstract][Full Text] [Related]
18. Autoimmune manifestations in aged mice arise from early-life immune dysregulation.
Mahmoud TI; Wang J; Karnell JL; Wang Q; Wang S; Naiman B; Gross P; Brohawn PZ; Morehouse C; Aoyama J; Wasserfall C; Carter L; Atkinson MA; Serreze DV; Braley-Mullen H; Mustelin T; Kolbeck R; Herbst R; Ettinger R
Sci Transl Med; 2016 Oct; 8(361):361ra137. PubMed ID: 27798262
[TBL] [Abstract][Full Text] [Related]
19. IL-17 and CCR9
Hwang SH; Woo JS; Moon J; Yang S; Park JS; Lee J; Choi J; Lee KH; Kwok SK; Park SH; Cho ML
Front Immunol; 2021; 12():721453. PubMed ID: 34539657
[TBL] [Abstract][Full Text] [Related]
20. Autoimmune B Cell Repertoire in a Mouse Model of Sjögren's Syndrome.
Sáez Moya M; Gutiérrez-Cózar R; Puñet-Ortiz J; Rodríguez de la Concepción ML; Blanco J; Carrillo J; Engel P
Front Immunol; 2021; 12():666545. PubMed ID: 33968069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
